Berman Capital Advisors’s Spyre Therapeutics SYRE Stock Holding History

Berman Capital Advisors’s Portfolio SYRE Stock Details SYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$0	Buy
2020 Q3	–	Sell
2020 Q2	$5K	Buy